Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 24;205(8):296.
doi: 10.1007/s00203-023-03632-7.

Therapeutic and immunomodulatory role of probiotics in breast cancer: A mechanistic review

Muhammad Summer  1 , Shaukat Ali  2 , Umaima Fiaz  1 , Hafiz Muhammad Tahir  1 , Muhammad Ijaz  3 , Shumaila Mumtaz  1 , Rabia Mushtaq  1 , Rida Khan  1 , Hafsa Shahzad  1 , Hashim Fiaz  4
Affiliations
Review

Therapeutic and immunomodulatory role of probiotics in breast cancer: A mechanistic review

Muhammad Summer et al. Arch Microbiol. .

Abstract

Breast cancer has become the most prevalent and noxious type of malignancy around the globe (Giaquinto et al., 2022). Multiple clinical strategies including chemotherapy, radiotherapy, and immunotherapy have been in practice to manage breast cancer. Besides the protective roles of conventional remedial approaches, and non-reversible and deteriorative impacts like healthy cell damage, organ failure, etc., the world scientific community is in a continuous struggle to find some alternative biocompatible and comparatively safe solutions. Among novel breast cancer management/treatment options, the role of probiotics has become immensely important. The current review encompasses the prevalence statistics of breast cancer across the globe concerning developed and undeveloped counties, intestinal microbiota linkage with breast cancer, and association of breast microbiome with breast carcinoma. Furthermore, this review also narrates the role of probiotics against breast cancer and their mode of action. In Vivo and In Vitro studies under breast cancer research regarding probiotics are mechanistically explained. The current review systematically explains the immunomodulatory role of probiotics to prevent breast cancer. Last, but not the least, current review concludes the use of probiotics in the treatment of breast cancer through various mechanisms and future recommendations for molecular basis studies.

Keywords: Cancer; Immunomodulatory; Microbiome; Probiotics.

PubMed Disclaimer

References

    1. Abdoli M, Fathi Rezaei P, Mansouri K (2021) Exploring the anticancer efficacy of mixture of local probiotics on MDA-MB-231 and MCF-7 breast cell lines. Journal of Cell and Molecular Research 13(1):54–64
    1. Abreu MT, Fukata M, Arditi M (2005) TLR signaling in the gut in health and disease. J Immunol 174(8):4453–4460 - PubMed - DOI
    1. Albert-Bayo M, Paracuellos I, González-Castro AM, Rodríguez-Urrutia A, Rodríguez-Lagunas MJ, Alonso-Cotoner C et al (2019) Intestinal mucosal mast cells: key modulators of barrier function and homeostasis. Cells 8(2):135 - PubMed - PMC - DOI
    1. Anderson RC, Cookson AL, McNabb WC, Kelly WJ, Roy NC (2010) Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function. FEMS Microbiology Letters 309(2):184–192
    1. Aragón F, Carino S, Perdigón G, de LeBlanc ADM (2014) The administration of milk fermented by the probiotic Lactobacillus casei CRL 431 exerts an immunomodulatory effect against a breast tumour in a mouse model. Immunobiology 219(6):457–464

LinkOut - more resources